Wed, August 2, 2023
Tue, August 1, 2023
Mon, July 31, 2023

Mayank Mamtani Reiterated (TGTX) at Strong Buy with Decreased Target to $32 on, Aug 1st, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-32-on-aug-1st-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Mayank Mamtani of B. Riley Securities, Reiterated "TG Therapeutics, Inc." (TGTX) at Strong Buy with Decreased Target from $42 to $32 on, Aug 1st, 2023.

Mayank has made no other calls on TGTX in the last 4 months.



There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mayank


  • Corinne Jenkins of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $16 on, Tuesday, July 25th, 2023
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $38 on, Tuesday, May 2nd, 2023
  • Prakhar Agrawal of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $24 on, Monday, April 17th, 2023

Publication Contributing Sources